Hannover Rück SE
HNR1
주식 순위
#627
Hannover Rück SE, along with its group entities, offers a broad spectrum of... Hannover Rück SE, along with its group entities, offers a broad spectrum of reinsurance products and services worldwide. Operations are structured around two principal segments: Property & Casualty Reinsurance, and Life & Health Reinsurance. Within Property & Casualty Reinsurance, its offerings span traditional property and casualty coverage, facultative arrangements, extensive catastrophe excess-of-loss protection, custom-tailored structured reinsurance, and innovative insurance-linked securities. The company further specializes in risk solutions for agriculture, livestock, bloodstock, aviation, space, marine, and offshore energy industries, in addition to providing coverage for credit, surety, and political risks. Its Life & Health Reinsurance segment encompasses a range of products including group and individual credit life, enhanced annuities, collective life and health schemes, and Takaful reinsurance. It also engineers risk solutions addressing critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm delivers diverse financial solutions, such as financing new business ventures, monetizing embedded value, providing reserve and solvency relief, and assisting with the divestiture of non-core operations. Founded in 1966, the company maintains its headquarters in Hanover, Germany. It was formerly known as Hannover Rückversicherung AG before rebranding to Hannover Rück SE in March 2013. Hannover Rück SE functions as a subsidiary of Talanx AG.
주가
$314.89
시가총액
$37.98B
변동 (1일)
1.01%
변동 (1년)
5.35%
국가
DE
거래 Hannover Rück SE (HNR1)
카테고리
Financial Services
Hannover Rück SE (HNR1)의 발행 주식 수
October 2026 기준 발행 주식 수: 0
Hannover Rück SE의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 0입니다. October 2026 말 기준 회사는 0주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Hannover Rück SE (HNR1)의 발행 주식 수 기록 (2002 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2025 | 120.60M | 0.00% |
| 2024 | 120.60M | 0.00% |
| 2023 | 120.60M | 0.00% |
| 2022 | 120.60M | 0.00% |
| 2021 | 120.60M | 0.00% |
| 2020 | 120.60M | 0.00% |
| 2019 | 120.60M | 0.00% |
| 2018 | 120.60M | 0.00% |
| 2017 | 120.60M | 0.00% |
| 2016 | 120.60M | 0.00% |
| 2015 | 120.60M | 0.00% |
| 2014 | 120.60M | 0.00% |
| 2013 | 120.60M | 0.00% |
| 2012 | 120.60M | 0.00% |
| 2011 | 120.60M | 0.00% |
| 2010 | 120.60M | 0.00% |
| 2009 | 120.59M | 0.00% |
| 2008 | 120.59M | 0.00% |
| 2007 | 120.60M | 0.00% |
| 2006 | 120.60M | 0.00% |
| 2005 | 120.60M | 0.00% |
| 2004 | 120.60M | 3.76% |
| 2003 | 116.22M | 4.82% |
| 2002 | 110.88M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
CH
|
|
| 66.09M | - |
US
|
|
| - | - |
US
|
